Recent advances in the management of renal cell carcinoma

Ana M Molina; David M Nanus

doi:10.12688/f1000research.7935.1

Recent advances in the management of renal cell carcinoma

F1000Res. 2016 Mar 23:5:F1000 Faculty Rev-391. doi: 10.12688/f1000research.7935.1. eCollection 2016.

Authors

Ana M Molina¹, David M Nanus¹

Affiliation

¹ Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, 1300 York Avenue, New York, NY, 10065 , USA; Meyer Cancer Center, Weill Cornell Medicine, 1300 York Avenue, New York, NY, 10065 , USA.

Abstract

Therapeutic options for patients with metastatic renal cell carcinoma have significantly improved over the past few years with the recent approval of two new agents resulting in prolonged progression-free and overall survival.

Keywords: cancer; kidney; management; renal cell carcinoma; therapy.

Publication types

Review

Grants and funding

The author(s) declared that no grants were involved in supporting this work.